nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—hypertension—type 2 diabetes mellitus	0.463	1	CtDrD
Betaxolol—CYP1A2—type 2 diabetes mellitus	0.185	1	CbGaD
Betaxolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.055	0.284	CbGbCtD
Betaxolol—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0228	0.118	CbGbCtD
Betaxolol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0204	0.105	CbGbCtD
Betaxolol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0188	0.0971	CbGbCtD
Betaxolol—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.018	0.0927	CbGbCtD
Betaxolol—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.017	0.0877	CbGbCtD
Betaxolol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0154	0.0797	CbGbCtD
Betaxolol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0148	0.0764	CbGbCtD
Betaxolol—CYP1A2—Losartan—type 2 diabetes mellitus	0.0116	0.0598	CbGbCtD
Betaxolol—Alprenolol—ADRB3—type 2 diabetes mellitus	0.000552	0.302	CrCbGaD
Betaxolol—Pindolol—ADRB3—type 2 diabetes mellitus	0.000475	0.26	CrCbGaD
Betaxolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.000259	0.142	CrCbGaD
Betaxolol—Chlorphenesin—CYP3A4—type 2 diabetes mellitus	0.000137	0.0751	CrCbGaD
Betaxolol—Chlorphenesin—PTGS2—type 2 diabetes mellitus	0.000134	0.0735	CrCbGaD
Betaxolol—Bisoprolol—CYP3A4—type 2 diabetes mellitus	0.000134	0.0732	CrCbGaD
Betaxolol—Propranolol—CYP1A2—type 2 diabetes mellitus	8.14e-05	0.0446	CrCbGaD
Betaxolol—Propranolol—CYP3A4—type 2 diabetes mellitus	5.39e-05	0.0295	CrCbGaD
Betaxolol—Rash—Sitagliptin—type 2 diabetes mellitus	5.18e-05	0.000426	CcSEcCtD
Betaxolol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	5.17e-05	0.000426	CcSEcCtD
Betaxolol—Headache—Glimepiride—type 2 diabetes mellitus	5.16e-05	0.000425	CcSEcCtD
Betaxolol—Ill-defined disorder—Losartan—type 2 diabetes mellitus	5.15e-05	0.000424	CcSEcCtD
Betaxolol—Cough—Irbesartan—type 2 diabetes mellitus	5.15e-05	0.000424	CcSEcCtD
Betaxolol—Headache—Sitagliptin—type 2 diabetes mellitus	5.14e-05	0.000423	CcSEcCtD
Betaxolol—Anaemia—Losartan—type 2 diabetes mellitus	5.13e-05	0.000422	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	5.11e-05	0.00042	CcSEcCtD
Betaxolol—Oedema—Metformin—type 2 diabetes mellitus	5.1e-05	0.00042	CcSEcCtD
Betaxolol—Tinnitus—Ramipril—type 2 diabetes mellitus	5.1e-05	0.00042	CcSEcCtD
Betaxolol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.08e-05	0.000418	CcSEcCtD
Betaxolol—Flushing—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000418	CcSEcCtD
Betaxolol—Infection—Metformin—type 2 diabetes mellitus	5.07e-05	0.000417	CcSEcCtD
Betaxolol—Insomnia—Valsartan—type 2 diabetes mellitus	5.07e-05	0.000417	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	5.05e-05	0.000415	CcSEcCtD
Betaxolol—Paraesthesia—Valsartan—type 2 diabetes mellitus	5.03e-05	0.000414	CcSEcCtD
Betaxolol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	5.03e-05	0.000414	CcSEcCtD
Betaxolol—Myalgia—Irbesartan—type 2 diabetes mellitus	5.02e-05	0.000413	CcSEcCtD
Betaxolol—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.02e-05	0.000413	CcSEcCtD
Betaxolol—Chest pain—Irbesartan—type 2 diabetes mellitus	5.02e-05	0.000413	CcSEcCtD
Betaxolol—Shock—Metformin—type 2 diabetes mellitus	5.02e-05	0.000413	CcSEcCtD
Betaxolol—Insomnia—Orlistat—type 2 diabetes mellitus	5.01e-05	0.000412	CcSEcCtD
Betaxolol—Malaise—Losartan—type 2 diabetes mellitus	5.01e-05	0.000412	CcSEcCtD
Betaxolol—Anxiety—Irbesartan—type 2 diabetes mellitus	5.01e-05	0.000412	CcSEcCtD
Betaxolol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.01e-05	0.000412	CcSEcCtD
Betaxolol—Nervous system disorder—Metformin—type 2 diabetes mellitus	5.01e-05	0.000412	CcSEcCtD
Betaxolol—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5e-05	0.000411	CcSEcCtD
Betaxolol—Dyspnoea—Valsartan—type 2 diabetes mellitus	5e-05	0.000411	CcSEcCtD
Betaxolol—Vertigo—Losartan—type 2 diabetes mellitus	4.99e-05	0.00041	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.99e-05	0.00041	CcSEcCtD
Betaxolol—Syncope—Losartan—type 2 diabetes mellitus	4.98e-05	0.00041	CcSEcCtD
Betaxolol—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.97e-05	0.000409	CcSEcCtD
Betaxolol—Discomfort—Irbesartan—type 2 diabetes mellitus	4.96e-05	0.000408	CcSEcCtD
Betaxolol—Skin disorder—Metformin—type 2 diabetes mellitus	4.96e-05	0.000408	CcSEcCtD
Betaxolol—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000406	CcSEcCtD
Betaxolol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.93e-05	0.000406	CcSEcCtD
Betaxolol—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.93e-05	0.000406	CcSEcCtD
Betaxolol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.93e-05	0.000406	CcSEcCtD
Betaxolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.91e-05	0.000404	CcSEcCtD
Betaxolol—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.91e-05	0.000404	CcSEcCtD
Betaxolol—Palpitations—Losartan—type 2 diabetes mellitus	4.91e-05	0.000404	CcSEcCtD
Betaxolol—Nausea—Glimepiride—type 2 diabetes mellitus	4.89e-05	0.000403	CcSEcCtD
Betaxolol—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000402	CcSEcCtD
Betaxolol—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.88e-05	0.000402	CcSEcCtD
Betaxolol—Nausea—Sitagliptin—type 2 diabetes mellitus	4.88e-05	0.000401	CcSEcCtD
Betaxolol—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.87e-05	0.000401	CcSEcCtD
Betaxolol—Asthenia—Glyburide—type 2 diabetes mellitus	4.87e-05	0.000401	CcSEcCtD
Betaxolol—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.87e-05	0.000401	CcSEcCtD
Betaxolol—Anorexia—Metformin—type 2 diabetes mellitus	4.86e-05	0.0004	CcSEcCtD
Betaxolol—Cough—Losartan—type 2 diabetes mellitus	4.85e-05	0.000399	CcSEcCtD
Betaxolol—Urticaria—Gliclazide—type 2 diabetes mellitus	4.85e-05	0.000399	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.84e-05	0.000398	CcSEcCtD
Betaxolol—Alopecia—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000398	CcSEcCtD
Betaxolol—Fatigue—Valsartan—type 2 diabetes mellitus	4.83e-05	0.000397	CcSEcCtD
Betaxolol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.82e-05	0.000397	CcSEcCtD
Betaxolol—Oedema—Irbesartan—type 2 diabetes mellitus	4.82e-05	0.000396	CcSEcCtD
Betaxolol—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.81e-05	0.000396	CcSEcCtD
Betaxolol—Pruritus—Glyburide—type 2 diabetes mellitus	4.81e-05	0.000395	CcSEcCtD
Betaxolol—Mental disorder—Ramipril—type 2 diabetes mellitus	4.79e-05	0.000394	CcSEcCtD
Betaxolol—Constipation—Valsartan—type 2 diabetes mellitus	4.79e-05	0.000394	CcSEcCtD
Betaxolol—Infection—Irbesartan—type 2 diabetes mellitus	4.78e-05	0.000394	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.78e-05	0.000393	CcSEcCtD
Betaxolol—Fatigue—Orlistat—type 2 diabetes mellitus	4.77e-05	0.000393	CcSEcCtD
Betaxolol—Hypotension—Metformin—type 2 diabetes mellitus	4.77e-05	0.000392	CcSEcCtD
Betaxolol—Erythema—Ramipril—type 2 diabetes mellitus	4.76e-05	0.000392	CcSEcCtD
Betaxolol—Malnutrition—Ramipril—type 2 diabetes mellitus	4.76e-05	0.000392	CcSEcCtD
Betaxolol—Shock—Irbesartan—type 2 diabetes mellitus	4.74e-05	0.00039	CcSEcCtD
Betaxolol—Pain—Orlistat—type 2 diabetes mellitus	4.74e-05	0.00039	CcSEcCtD
Betaxolol—Chest pain—Losartan—type 2 diabetes mellitus	4.73e-05	0.000389	CcSEcCtD
Betaxolol—Myalgia—Losartan—type 2 diabetes mellitus	4.73e-05	0.000389	CcSEcCtD
Betaxolol—Arthralgia—Losartan—type 2 diabetes mellitus	4.73e-05	0.000389	CcSEcCtD
Betaxolol—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.72e-05	0.000389	CcSEcCtD
Betaxolol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.72e-05	0.000389	CcSEcCtD
Betaxolol—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.72e-05	0.000388	CcSEcCtD
Betaxolol—Anxiety—Losartan—type 2 diabetes mellitus	4.71e-05	0.000388	CcSEcCtD
Betaxolol—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.7e-05	0.000387	CcSEcCtD
Betaxolol—Rash—Bromocriptine—type 2 diabetes mellitus	4.69e-05	0.000385	CcSEcCtD
Betaxolol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.68e-05	0.000385	CcSEcCtD
Betaxolol—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.000385	CcSEcCtD
Betaxolol—Tension—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000384	CcSEcCtD
Betaxolol—Discomfort—Losartan—type 2 diabetes mellitus	4.67e-05	0.000384	CcSEcCtD
Betaxolol—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.66e-05	0.000384	CcSEcCtD
Betaxolol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.66e-05	0.000383	CcSEcCtD
Betaxolol—Headache—Bromocriptine—type 2 diabetes mellitus	4.66e-05	0.000383	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.65e-05	0.000383	CcSEcCtD
Betaxolol—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.65e-05	0.000382	CcSEcCtD
Betaxolol—Nervousness—Ramipril—type 2 diabetes mellitus	4.63e-05	0.00038	CcSEcCtD
Betaxolol—Dry mouth—Losartan—type 2 diabetes mellitus	4.62e-05	0.00038	CcSEcCtD
Betaxolol—Anorexia—Irbesartan—type 2 diabetes mellitus	4.59e-05	0.000378	CcSEcCtD
Betaxolol—Paraesthesia—Metformin—type 2 diabetes mellitus	4.58e-05	0.000377	CcSEcCtD
Betaxolol—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.58e-05	0.000377	CcSEcCtD
Betaxolol—Confusional state—Losartan—type 2 diabetes mellitus	4.57e-05	0.000376	CcSEcCtD
Betaxolol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.56e-05	0.000375	CcSEcCtD
Betaxolol—Dyspnoea—Metformin—type 2 diabetes mellitus	4.55e-05	0.000374	CcSEcCtD
Betaxolol—Oedema—Losartan—type 2 diabetes mellitus	4.53e-05	0.000373	CcSEcCtD
Betaxolol—Infection—Losartan—type 2 diabetes mellitus	4.5e-05	0.00037	CcSEcCtD
Betaxolol—Hypotension—Irbesartan—type 2 diabetes mellitus	4.5e-05	0.00037	CcSEcCtD
Betaxolol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.49e-05	0.00037	CcSEcCtD
Betaxolol—Dyspepsia—Metformin—type 2 diabetes mellitus	4.49e-05	0.00037	CcSEcCtD
Betaxolol—Tremor—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000367	CcSEcCtD
Betaxolol—Shock—Losartan—type 2 diabetes mellitus	4.46e-05	0.000367	CcSEcCtD
Betaxolol—Urticaria—Valsartan—type 2 diabetes mellitus	4.45e-05	0.000366	CcSEcCtD
Betaxolol—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.45e-05	0.000366	CcSEcCtD
Betaxolol—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.44e-05	0.000365	CcSEcCtD
Betaxolol—Decreased appetite—Metformin—type 2 diabetes mellitus	4.44e-05	0.000365	CcSEcCtD
Betaxolol—Tachycardia—Losartan—type 2 diabetes mellitus	4.42e-05	0.000364	CcSEcCtD
Betaxolol—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.42e-05	0.000363	CcSEcCtD
Betaxolol—Nausea—Bromocriptine—type 2 diabetes mellitus	4.41e-05	0.000363	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.41e-05	0.000362	CcSEcCtD
Betaxolol—Fatigue—Metformin—type 2 diabetes mellitus	4.4e-05	0.000362	CcSEcCtD
Betaxolol—Urticaria—Orlistat—type 2 diabetes mellitus	4.4e-05	0.000362	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000361	CcSEcCtD
Betaxolol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.38e-05	0.00036	CcSEcCtD
Betaxolol—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.38e-05	0.00036	CcSEcCtD
Betaxolol—Asthenia—Gliclazide—type 2 diabetes mellitus	4.38e-05	0.00036	CcSEcCtD
Betaxolol—Constipation—Metformin—type 2 diabetes mellitus	4.36e-05	0.000359	CcSEcCtD
Betaxolol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.32e-05	0.000356	CcSEcCtD
Betaxolol—Anorexia—Losartan—type 2 diabetes mellitus	4.32e-05	0.000355	CcSEcCtD
Betaxolol—Vomiting—Glyburide—type 2 diabetes mellitus	4.32e-05	0.000355	CcSEcCtD
Betaxolol—Pruritus—Gliclazide—type 2 diabetes mellitus	4.32e-05	0.000355	CcSEcCtD
Betaxolol—Malaise—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000353	CcSEcCtD
Betaxolol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.29e-05	0.000353	CcSEcCtD
Betaxolol—Rash—Glyburide—type 2 diabetes mellitus	4.28e-05	0.000352	CcSEcCtD
Betaxolol—Dermatitis—Glyburide—type 2 diabetes mellitus	4.28e-05	0.000352	CcSEcCtD
Betaxolol—Vertigo—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000352	CcSEcCtD
Betaxolol—Syncope—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000351	CcSEcCtD
Betaxolol—Headache—Glyburide—type 2 diabetes mellitus	4.26e-05	0.00035	CcSEcCtD
Betaxolol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.24e-05	0.000349	CcSEcCtD
Betaxolol—Hypotension—Losartan—type 2 diabetes mellitus	4.24e-05	0.000348	CcSEcCtD
Betaxolol—Palpitations—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000346	CcSEcCtD
Betaxolol—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.21e-05	0.000346	CcSEcCtD
Betaxolol—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.19e-05	0.000344	CcSEcCtD
Betaxolol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.19e-05	0.000344	CcSEcCtD
Betaxolol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.17e-05	0.000343	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.16e-05	0.000342	CcSEcCtD
Betaxolol—Cough—Ramipril—type 2 diabetes mellitus	4.16e-05	0.000342	CcSEcCtD
Betaxolol—Fatigue—Irbesartan—type 2 diabetes mellitus	4.15e-05	0.000342	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.13e-05	0.00034	CcSEcCtD
Betaxolol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.13e-05	0.00034	CcSEcCtD
Betaxolol—Pain—Irbesartan—type 2 diabetes mellitus	4.12e-05	0.000339	CcSEcCtD
Betaxolol—Constipation—Irbesartan—type 2 diabetes mellitus	4.12e-05	0.000339	CcSEcCtD
Betaxolol—Insomnia—Losartan—type 2 diabetes mellitus	4.1e-05	0.000337	CcSEcCtD
Betaxolol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.08e-05	0.000336	CcSEcCtD
Betaxolol—Paraesthesia—Losartan—type 2 diabetes mellitus	4.07e-05	0.000335	CcSEcCtD
Betaxolol—Urticaria—Metformin—type 2 diabetes mellitus	4.05e-05	0.000334	CcSEcCtD
Betaxolol—Arthralgia—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000334	CcSEcCtD
Betaxolol—Chest pain—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000334	CcSEcCtD
Betaxolol—Myalgia—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000334	CcSEcCtD
Betaxolol—Dyspnoea—Losartan—type 2 diabetes mellitus	4.04e-05	0.000332	CcSEcCtD
Betaxolol—Anxiety—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000332	CcSEcCtD
Betaxolol—Nausea—Glyburide—type 2 diabetes mellitus	4.04e-05	0.000332	CcSEcCtD
Betaxolol—Dizziness—Gliclazide—type 2 diabetes mellitus	4.03e-05	0.000332	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000331	CcSEcCtD
Betaxolol—Asthenia—Valsartan—type 2 diabetes mellitus	4.02e-05	0.000331	CcSEcCtD
Betaxolol—Discomfort—Ramipril—type 2 diabetes mellitus	4.01e-05	0.00033	CcSEcCtD
Betaxolol—Dyspepsia—Losartan—type 2 diabetes mellitus	3.99e-05	0.000328	CcSEcCtD
Betaxolol—Asthenia—Orlistat—type 2 diabetes mellitus	3.97e-05	0.000327	CcSEcCtD
Betaxolol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.97e-05	0.000327	CcSEcCtD
Betaxolol—Pruritus—Valsartan—type 2 diabetes mellitus	3.97e-05	0.000326	CcSEcCtD
Betaxolol—Dry mouth—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000326	CcSEcCtD
Betaxolol—Decreased appetite—Losartan—type 2 diabetes mellitus	3.94e-05	0.000324	CcSEcCtD
Betaxolol—Confusional state—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000322	CcSEcCtD
Betaxolol—Pruritus—Orlistat—type 2 diabetes mellitus	3.92e-05	0.000322	CcSEcCtD
Betaxolol—Fatigue—Losartan—type 2 diabetes mellitus	3.91e-05	0.000321	CcSEcCtD
Betaxolol—Oedema—Ramipril—type 2 diabetes mellitus	3.89e-05	0.00032	CcSEcCtD
Betaxolol—Vomiting—Gliclazide—type 2 diabetes mellitus	3.88e-05	0.000319	CcSEcCtD
Betaxolol—Pain—Losartan—type 2 diabetes mellitus	3.88e-05	0.000319	CcSEcCtD
Betaxolol—Constipation—Losartan—type 2 diabetes mellitus	3.88e-05	0.000319	CcSEcCtD
Betaxolol—Rash—Gliclazide—type 2 diabetes mellitus	3.85e-05	0.000316	CcSEcCtD
Betaxolol—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.84e-05	0.000316	CcSEcCtD
Betaxolol—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.83e-05	0.000315	CcSEcCtD
Betaxolol—Urticaria—Irbesartan—type 2 diabetes mellitus	3.83e-05	0.000315	CcSEcCtD
Betaxolol—Shock—Ramipril—type 2 diabetes mellitus	3.82e-05	0.000315	CcSEcCtD
Betaxolol—Headache—Gliclazide—type 2 diabetes mellitus	3.82e-05	0.000314	CcSEcCtD
Betaxolol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000314	CcSEcCtD
Betaxolol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.81e-05	0.000313	CcSEcCtD
Betaxolol—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000313	CcSEcCtD
Betaxolol—Tachycardia—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000312	CcSEcCtD
Betaxolol—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.79e-05	0.000312	CcSEcCtD
Betaxolol—Skin disorder—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000311	CcSEcCtD
Betaxolol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000309	CcSEcCtD
Betaxolol—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.74e-05	0.000307	CcSEcCtD
Betaxolol—Dizziness—Valsartan—type 2 diabetes mellitus	3.71e-05	0.000305	CcSEcCtD
Betaxolol—Anorexia—Ramipril—type 2 diabetes mellitus	3.7e-05	0.000305	CcSEcCtD
Betaxolol—Dizziness—Orlistat—type 2 diabetes mellitus	3.66e-05	0.000301	CcSEcCtD
Betaxolol—Asthenia—Metformin—type 2 diabetes mellitus	3.66e-05	0.000301	CcSEcCtD
Betaxolol—Hypotension—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000299	CcSEcCtD
Betaxolol—Nausea—Gliclazide—type 2 diabetes mellitus	3.62e-05	0.000298	CcSEcCtD
Betaxolol—Pruritus—Metformin—type 2 diabetes mellitus	3.61e-05	0.000297	CcSEcCtD
Betaxolol—Urticaria—Losartan—type 2 diabetes mellitus	3.6e-05	0.000296	CcSEcCtD
Betaxolol—Body temperature increased—Losartan—type 2 diabetes mellitus	3.58e-05	0.000295	CcSEcCtD
Betaxolol—Vomiting—Valsartan—type 2 diabetes mellitus	3.56e-05	0.000293	CcSEcCtD
Betaxolol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.55e-05	0.000292	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000291	CcSEcCtD
Betaxolol—Rash—Valsartan—type 2 diabetes mellitus	3.53e-05	0.000291	CcSEcCtD
Betaxolol—Dermatitis—Valsartan—type 2 diabetes mellitus	3.53e-05	0.00029	CcSEcCtD
Betaxolol—Vomiting—Orlistat—type 2 diabetes mellitus	3.52e-05	0.00029	CcSEcCtD
Betaxolol—Insomnia—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000289	CcSEcCtD
Betaxolol—Headache—Valsartan—type 2 diabetes mellitus	3.51e-05	0.000289	CcSEcCtD
Betaxolol—Diarrhoea—Metformin—type 2 diabetes mellitus	3.49e-05	0.000287	CcSEcCtD
Betaxolol—Rash—Orlistat—type 2 diabetes mellitus	3.49e-05	0.000287	CcSEcCtD
Betaxolol—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.49e-05	0.000287	CcSEcCtD
Betaxolol—Dermatitis—Orlistat—type 2 diabetes mellitus	3.49e-05	0.000287	CcSEcCtD
Betaxolol—Headache—Orlistat—type 2 diabetes mellitus	3.47e-05	0.000285	CcSEcCtD
Betaxolol—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000285	CcSEcCtD
Betaxolol—Asthenia—Irbesartan—type 2 diabetes mellitus	3.46e-05	0.000284	CcSEcCtD
Betaxolol—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000281	CcSEcCtD
Betaxolol—Pruritus—Irbesartan—type 2 diabetes mellitus	3.41e-05	0.00028	CcSEcCtD
Betaxolol—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000278	CcSEcCtD
Betaxolol—Dizziness—Metformin—type 2 diabetes mellitus	3.37e-05	0.000278	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.36e-05	0.000276	CcSEcCtD
Betaxolol—Fatigue—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000276	CcSEcCtD
Betaxolol—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.34e-05	0.000275	CcSEcCtD
Betaxolol—Nausea—Valsartan—type 2 diabetes mellitus	3.33e-05	0.000274	CcSEcCtD
Betaxolol—Constipation—Ramipril—type 2 diabetes mellitus	3.32e-05	0.000273	CcSEcCtD
Betaxolol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.3e-05	0.000271	CcSEcCtD
Betaxolol—Nausea—Orlistat—type 2 diabetes mellitus	3.29e-05	0.000271	CcSEcCtD
Betaxolol—Asthenia—Losartan—type 2 diabetes mellitus	3.25e-05	0.000268	CcSEcCtD
Betaxolol—Vomiting—Metformin—type 2 diabetes mellitus	3.25e-05	0.000267	CcSEcCtD
Betaxolol—Rash—Metformin—type 2 diabetes mellitus	3.22e-05	0.000265	CcSEcCtD
Betaxolol—Dermatitis—Metformin—type 2 diabetes mellitus	3.22e-05	0.000264	CcSEcCtD
Betaxolol—Pruritus—Losartan—type 2 diabetes mellitus	3.21e-05	0.000264	CcSEcCtD
Betaxolol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000263	CcSEcCtD
Betaxolol—Headache—Metformin—type 2 diabetes mellitus	3.2e-05	0.000263	CcSEcCtD
Betaxolol—Dizziness—Irbesartan—type 2 diabetes mellitus	3.18e-05	0.000262	CcSEcCtD
Betaxolol—Diarrhoea—Losartan—type 2 diabetes mellitus	3.1e-05	0.000255	CcSEcCtD
Betaxolol—Urticaria—Ramipril—type 2 diabetes mellitus	3.09e-05	0.000254	CcSEcCtD
Betaxolol—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000253	CcSEcCtD
Betaxolol—Vomiting—Irbesartan—type 2 diabetes mellitus	3.06e-05	0.000252	CcSEcCtD
Betaxolol—Rash—Irbesartan—type 2 diabetes mellitus	3.04e-05	0.00025	CcSEcCtD
Betaxolol—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.03e-05	0.00025	CcSEcCtD
Betaxolol—Nausea—Metformin—type 2 diabetes mellitus	3.03e-05	0.000249	CcSEcCtD
Betaxolol—Headache—Irbesartan—type 2 diabetes mellitus	3.02e-05	0.000248	CcSEcCtD
Betaxolol—Dizziness—Losartan—type 2 diabetes mellitus	3e-05	0.000247	CcSEcCtD
Betaxolol—Vomiting—Losartan—type 2 diabetes mellitus	2.88e-05	0.000237	CcSEcCtD
Betaxolol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.86e-05	0.000236	CcSEcCtD
Betaxolol—Nausea—Irbesartan—type 2 diabetes mellitus	2.86e-05	0.000235	CcSEcCtD
Betaxolol—Rash—Losartan—type 2 diabetes mellitus	2.86e-05	0.000235	CcSEcCtD
Betaxolol—Dermatitis—Losartan—type 2 diabetes mellitus	2.86e-05	0.000235	CcSEcCtD
Betaxolol—Headache—Losartan—type 2 diabetes mellitus	2.84e-05	0.000234	CcSEcCtD
Betaxolol—Asthenia—Ramipril—type 2 diabetes mellitus	2.79e-05	0.000229	CcSEcCtD
Betaxolol—Pruritus—Ramipril—type 2 diabetes mellitus	2.75e-05	0.000226	CcSEcCtD
Betaxolol—Nausea—Losartan—type 2 diabetes mellitus	2.69e-05	0.000221	CcSEcCtD
Betaxolol—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.66e-05	0.000219	CcSEcCtD
Betaxolol—Dizziness—Ramipril—type 2 diabetes mellitus	2.57e-05	0.000211	CcSEcCtD
Betaxolol—Vomiting—Ramipril—type 2 diabetes mellitus	2.47e-05	0.000203	CcSEcCtD
Betaxolol—Rash—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000202	CcSEcCtD
Betaxolol—Dermatitis—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000201	CcSEcCtD
Betaxolol—Headache—Ramipril—type 2 diabetes mellitus	2.43e-05	0.0002	CcSEcCtD
Betaxolol—Nausea—Ramipril—type 2 diabetes mellitus	2.31e-05	0.00019	CcSEcCtD
Betaxolol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.36e-06	0.00024	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.36e-06	0.00024	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	8.36e-06	0.00024	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	8.36e-06	0.00024	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.26e-06	0.000237	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	8.22e-06	0.000236	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.18e-06	0.000235	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.18e-06	0.000235	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	8.11e-06	0.000233	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	8.11e-06	0.000233	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	8.11e-06	0.000233	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.08e-06	0.000232	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.03e-06	0.000231	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	8.02e-06	0.00023	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	7.86e-06	0.000226	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.78e-06	0.000223	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	7.77e-06	0.000223	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	7.77e-06	0.000223	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	7.74e-06	0.000222	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	7.65e-06	0.00022	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.65e-06	0.00022	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.61e-06	0.000218	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	7.58e-06	0.000217	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.53e-06	0.000216	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	7.51e-06	0.000216	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.5e-06	0.000215	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	7.48e-06	0.000215	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	7.48e-06	0.000215	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	7.48e-06	0.000215	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.48e-06	0.000215	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.36e-06	0.000211	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	7.35e-06	0.000211	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	7.35e-06	0.000211	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.34e-06	0.000211	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	7.25e-06	0.000208	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	7.25e-06	0.000208	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	7.25e-06	0.000208	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	7.25e-06	0.000208	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	7.23e-06	0.000207	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	7.23e-06	0.000207	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	7.23e-06	0.000207	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.16e-06	0.000205	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.03e-06	0.000202	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.03e-06	0.000202	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	7.01e-06	0.000201	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7e-06	0.000201	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	6.95e-06	0.0002	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.88e-06	0.000197	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.87e-06	0.000197	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	6.79e-06	0.000195	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	6.69e-06	0.000192	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.65e-06	0.000191	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.59e-06	0.000189	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.53e-06	0.000187	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.51e-06	0.000187	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.5e-06	0.000187	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	6.5e-06	0.000187	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.48e-06	0.000186	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	6.47e-06	0.000186	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.45e-06	0.000185	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.45e-06	0.000185	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.38e-06	0.000183	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	6.36e-06	0.000183	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	6.36e-06	0.000183	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.36e-06	0.000183	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.36e-06	0.000182	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.33e-06	0.000182	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.31e-06	0.000181	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	6.29e-06	0.00018	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.26e-06	0.00018	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.24e-06	0.000179	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.19e-06	0.000178	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	6.15e-06	0.000176	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	6.14e-06	0.000176	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	6.14e-06	0.000176	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	6.14e-06	0.000176	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	6.14e-06	0.000176	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.12e-06	0.000176	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.05e-06	0.000174	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	6.04e-06	0.000173	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	6e-06	0.000172	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	5.91e-06	0.00017	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	5.91e-06	0.00017	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.91e-06	0.00017	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	5.89e-06	0.000169	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.88e-06	0.000169	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	5.87e-06	0.000169	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	5.8e-06	0.000166	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	5.76e-06	0.000165	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	5.76e-06	0.000165	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	5.76e-06	0.000165	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.75e-06	0.000165	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	5.73e-06	0.000164	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.72e-06	0.000164	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.63e-06	0.000162	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	5.62e-06	0.000161	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.61e-06	0.000161	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	5.56e-06	0.00016	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.54e-06	0.000159	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.53e-06	0.000159	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.51e-06	0.000158	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	5.48e-06	0.000157	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.41e-06	0.000155	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	5.4e-06	0.000155	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	5.29e-06	0.000152	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	5.17e-06	0.000148	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	5.17e-06	0.000148	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	5.17e-06	0.000148	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.15e-06	0.000148	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.14e-06	0.000148	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.13e-06	0.000147	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.11e-06	0.000147	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.07e-06	0.000146	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.05e-06	0.000145	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.04e-06	0.000145	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.03e-06	0.000144	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.03e-06	0.000144	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.03e-06	0.000144	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.03e-06	0.000144	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	5.02e-06	0.000144	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.01e-06	0.000144	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.01e-06	0.000144	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.97e-06	0.000143	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.94e-06	0.000142	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.92e-06	0.000141	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.92e-06	0.000141	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.92e-06	0.000141	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.91e-06	0.000141	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.88e-06	0.00014	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	4.88e-06	0.00014	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	4.88e-06	0.00014	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	4.88e-06	0.00014	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.87e-06	0.00014	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.85e-06	0.000139	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.76e-06	0.000137	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.74e-06	0.000136	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.73e-06	0.000136	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.71e-06	0.000135	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.67e-06	0.000134	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.67e-06	0.000134	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.64e-06	0.000133	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.56e-06	0.000131	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.49e-06	0.000129	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.48e-06	0.000129	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.48e-06	0.000129	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.39e-06	0.000126	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.39e-06	0.000126	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.38e-06	0.000126	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.38e-06	0.000126	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.38e-06	0.000126	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	4.3e-06	0.000123	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.3e-06	0.000123	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.26e-06	0.000122	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.23e-06	0.000121	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	4.2e-06	0.000121	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.2e-06	0.000121	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.17e-06	0.00012	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.16e-06	0.000119	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.15e-06	0.000119	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.14e-06	0.000119	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.14e-06	0.000119	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.07e-06	0.000117	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.06e-06	0.000117	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.05e-06	0.000116	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4e-06	0.000115	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.96e-06	0.000114	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.95e-06	0.000113	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.86e-06	0.000111	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.86e-06	0.000111	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.86e-06	0.000111	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.86e-06	0.000111	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.84e-06	0.00011	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.84e-06	0.00011	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.8e-06	0.000109	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.8e-06	0.000109	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.79e-06	0.000109	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.77e-06	0.000108	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.77e-06	0.000108	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.69e-06	0.000106	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.69e-06	0.000106	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.68e-06	0.000106	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.58e-06	0.000103	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.55e-06	0.000102	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.52e-06	0.000101	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.47e-06	9.96e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.44e-06	9.88e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.43e-06	9.85e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.34e-06	9.59e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.3e-06	9.47e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.27e-06	9.39e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.27e-06	9.39e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.26e-06	9.35e-05	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.23e-06	9.27e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.21e-06	9.22e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.2e-06	9.18e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.18e-06	9.13e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.17e-06	9.09e-05	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.16e-06	9.07e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.13e-06	8.98e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.12e-06	8.95e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.11e-06	8.93e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.11e-06	8.92e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.03e-06	8.71e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.02e-06	8.68e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.01e-06	8.63e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.99e-06	8.59e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.98e-06	8.55e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.96e-06	8.49e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.96e-06	8.49e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.95e-06	8.46e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.93e-06	8.42e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.93e-06	8.4e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.92e-06	8.37e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.91e-06	8.36e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.91e-06	8.34e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.87e-06	8.24e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.83e-06	8.12e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.8e-06	8.02e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.79e-06	8e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.73e-06	7.83e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.72e-06	7.79e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.68e-06	7.7e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.66e-06	7.62e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.63e-06	7.55e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.57e-06	7.37e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.55e-06	7.31e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.52e-06	7.23e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.51e-06	7.19e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.5e-06	7.17e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.49e-06	7.15e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.47e-06	7.09e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.44e-06	7.01e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.44e-06	7e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.39e-06	6.86e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.31e-06	6.63e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.21e-06	6.34e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.21e-06	6.34e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.17e-06	6.24e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.13e-06	6.12e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.02e-06	5.8e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.96e-06	5.61e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.88e-06	5.39e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.87e-06	5.37e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.87e-06	5.37e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.84e-06	5.27e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.73e-06	4.97e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.71e-06	4.91e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.69e-06	4.86e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.02e-06	2.91e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	8.6e-07	2.47e-05	CbGpPWpGaD
